Bon Secours Mercy Health is in late-stage talks to buy a majority stake in Surgery Partners, valuing the group at about $20 a share, the Financial Times reports, citing people familiar with the matter.
Mostramos publicamente o ponto principal. Crie uma conta gratuita para continuar lendo o artigo completo, salva-lo, comenta-lo e conecta-lo ao contexto de mercado e OSINT.